|
Volumn 19, Issue 5, 2012, Pages 1425-1427
|
The role of adjuvant chemotherapy for localized squamous cell esophageal cancer: Current Japanese standard and the unending role of the drawing board
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CISPLATIN;
DOCETAXEL;
FLUOROURACIL;
CANCER ADJUVANT THERAPY;
CANCER CONTROL;
CANCER STAGING;
CANCER SURVIVAL;
COMPARATIVE STUDY;
EDITORIAL;
ESOPHAGEAL SQUAMOUS CELL CARCINOMA;
ESOPHAGUS RESECTION;
HUMAN;
JAPAN;
MEDICAL SOCIETY;
MULTIPLE CYCLE TREATMENT;
OUTCOME ASSESSMENT;
OVERALL SURVIVAL;
POSTOPERATIVE PERIOD;
PREOPERATIVE TREATMENT;
PROGRESSION FREE SURVIVAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SURVIVAL RATE;
TREATMENT INDICATION;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, SQUAMOUS CELL;
ESOPHAGEAL NEOPLASMS;
ESOPHAGECTOMY;
FEMALE;
HUMANS;
MALE;
NEOPLASM RECURRENCE, LOCAL;
|
EID: 84862549029
PISSN: 10689265
EISSN: 15344681
Source Type: Journal
DOI: 10.1245/s10434-012-2250-5 Document Type: Editorial |
Times cited : (7)
|
References (7)
|